US2011311965A1PendingUtilityA1
Methods of enhancing translocation of charged analytes through transmembrane protein pores
Est. expiryNov 14, 2028(~2.3 yrs left)· nominal 20-yr term from priority
G01N 33/48721C07K 14/245G01N 27/447G01N 33/6872G01N 2333/705C12Q 1/6869
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to enhancing translocation of a charged analyte through a transmembrane protein pore. Translocation is enhanced by increasing the net opposing charge of the barrel or channel and/or entrance of the pore. The invention also relates to pores enhanced in accordance with the invention.
Claims
exact text as granted — not AI-modified1 - 26 . (canceled)
27 . A method of enhancing translocation of a charged analyte through a transmembrane protein pore, comprising:
(a) increasing the net opposing charge of the barrel or channel and/or entrance of the pore; and (b) determining whether or not translocation of the analyte through the resulting pore is enhanced.
28 . A method according to claim 27 , wherein increasing the net opposing charge:
(a) increases the frequency of translocation of the analyte through the pore; (b) decreases the threshold voltage for translocation of the analyte through the pore; (c) decreases the translocation speed of the analyte through the pore; or (d) decreases the number of non-translocation interactions between the analyte and the pore.
29 . A method according to claim 27 , wherein the analyte is a polymer or a nucleic acid sequence.
30 . A method according to claim 27 , wherein the pore comprises:
(a) seven subunits each comprising SEQ ID NO: 2 or a variant thereof; or (b) seven subunits each comprising SEQ ID NO: 4 or a variant thereof.
31 . A method according to claim 27 , wherein the analyte is negatively charged and step (a) involves increasing the net positive charge.
32 . A method according to claim 31 , wherein the net positive charge is increased by introducing one or more positively charged amino acids into the barrel or channel and/or entrance of the pore.
33 . A method according to claim 32 , wherein the introducing is carried out by substitution.
34 . A method according to claim 33 , wherein the one or more positively-charge amino acids are histidine (H), lysine (K) and/or arginine (R).
35 . A method according to claim 31 , wherein the net positive charge is increased substituting one or more negatively charged amino acids in the barrel or channel and/or entrance of the pore with one or more uncharged amino acids, non-polar amino acids and/or aromatic amino acids.
36 . A method according to claim 27 , wherein the entrance is the portion of the pore through which the analyte enters the barrel or channel.
37 . A transmembrane protein pore enhanced by a method according to claim 27 .
38 . A transmembrane protein pore in which the net opposing charge of its barrel or channel and/or entrance has been increased to enhance the translocation of a charged analyte through the pore.
39 . A transmembrane protein pore according to claim 37 or 38 , wherein the pore comprises:
(a) at least one subunit comprising SEQ ID NO: 6 or a variant thereof;
(b) at least one subunit comprising SEQ ID NO: 8 or a variant thereof; or
(c) at least one subunit comprising SEQ ID NO: 10 or a variant thereof.
40 . A transmembrane protein pore according to claim 39 , wherein the pore is a homoheptamer comprising seven subunits of SEQ ID NO: 6, 8 or 10 or a variant thereof.
41 . A polynucleotide encoding a transmembrane protein pore according to claim 37 or 38 .
42 . A polynucleotide encoding a transmembrane protein pore subunit having the sequence of SEQ ID NO: 6, 8 or 10 or a variant thereof.
43 . A polynucleotide according to claim 42 , wherein the polynucleotide comprises the sequence shown in SEQ ID NO: 5, 7 or 9 or a variant thereof
44 . A method of determining presence or absence of an analyte in a sample, comprising:
(a) contacting the sample with a transmembrane protein pore according to claim 37 or 38 under conditions that allow the analyte, if present, to translocate through and interact with the pore; and (b) measuring the current passing through the pore during the interaction and thereby determining the presence or absence of the analyte.
45 . A method of sequencing a target nucleic acid sequence, comprising:
(a) pushing or pulling the target sequence through a transmembrane protein pore according to claims 37 to 38 so that a proportion of the nucleotides in the target sequence interact with the pore; and (b) measuring the current passing through the pore during each interaction and thereby determining the sequence of the target sequence.
46 . A kit for sequencing a nucleic acid, comprising a transmembrane protein pore according to claim 37 or 38 and a nucleic acid handling enzyme.Join the waitlist — get patent alerts
Track US2011311965A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.